1. [Clinical effect and influencing factors of focused ultrasound ablation surgery combined with suction curettage for the treatment of mass-type cesarean scar pregnancy].
- Author
-
Zhu XG, Shi QL, Deng XL, Xu W, and Xue M
- Subjects
- Cesarean Section adverse effects, Cicatrix complications, Female, Humans, Pregnancy, Uterine Hemorrhage etiology, Uterine Hemorrhage surgery, Vacuum Curettage adverse effects, Vacuum Curettage methods, High-Intensity Focused Ultrasound Ablation adverse effects, Pregnancy, Ectopic etiology, Pregnancy, Ectopic surgery
- Abstract
Objective: To investigate the clinical effect of focused ultrasound ablation surgery (FUAS) combined with suction curettage for mass-type cesarean scar pregnancy (CSP) and to analyze the influencing factors of vaginal bleeding and readmission. Methods: From January 2014 to December 2020, 88 patients with mass-type CSP were treated by FUAS combined with suction curettage in the Third Xiangya Hospital of Central South University. The clinical results and the influencing factors of bleeding and readmission for mass-type CSP were analyzed. Results: All the patients underwent one time FUAS treatment successfully. Immediately after FUAS treatment, color Doppler ultrasound showed obvious necrosis and no perfusion area in all lesions, and the blood flow in the mass-type CSP tissue significantly decreased. The median volume of blood loss in the procedure was 20 ml (range: 5-950 ml). Thirteen patients (15%, 13/88) had vaginal bleeding≥200 ml, and 15 patients (17%, 15/88) were hospitalized again. The average time for menstruation recovery was (28±8) days (range: 18-66 days). The average time needed for serum human chorionic gonadotropin-beta subunit to return to normal levels was (22±6) days (range: 7-59 days). The risk of large vaginal bleeding of patients were related to the blood supply of the mass ( OR =5.280, 95% CI : 1.335-20.858, P =0.018) and the largest diameter of the mass ( OR =1.060, 95% CI : 1.010-1.120, P =0.030). The risk of readmission were related to the largest diameter of the mass ( OR =1.055, 95% CI : 1.005-1.108, P =0.030) and the depth of the uterus cavity ( OR =1.583, 95% CI : 1.015-2.471, P =0.043). No serious complications such as intestinal and nerve injury occurred during and after FUAS treatment. Conclusions: FUAS combined with suction curettage is safe and effective in treating patients with mass-type CSP through this preliminary study. The volume of vaginal bleeding are associated with the blood supply of the mass and the largest diameter of the mass, the risk of readmission are related to the largest diameter of the mass and the depth of the uterus cavity.
- Published
- 2022
- Full Text
- View/download PDF